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Successful experimental and clinical experience 
with thrombus ablation has been attained with 
high-power acoustic energy delivered in a cathe- 
ter. The goal of this study was to investigate the 
feasibility of noninvasive thrombus ablation by fo- 
cused high-power acoustic energy. The source for 
high-power acoustic energy was a shock-wave 
generator in a water tank equipped with an acouss- 
tic lens with a fixed focal point at 22.5 cm. Throm- 
bus was prepared in vitro, weighed (0.24 f 0.08 
g), and inserted in excised human femoral artery 
segments. The arterial segments were ligated, po- 
sitioned at the focal point and then randomized 
into either test (n = 8) or control (n = 7). An x-ray 
system verified the $-dimensional positioning of 
the arterial segment at the focal point. A 5 MHz 
ultrasound imaging system continuously visual- 
ized the arterial segment at the focal point before, 
during and after each experiment. The test seg- 
ments were exposed to shock waves (1,000 
shocks/24 kv). The arterial segment content was 
then flushed and the residual thrombus weighed. 
The arterial segment and thrombus were fixed 
and submitted to histologic examination. The test 
group achieved a significant ablation of throm- 
bus mass (0.25 f 0.15 vs 0.07 f 0.003 g; p = 
0.0001) after application of shock waves. Arterial 
segments showed no gross or microscopic dam- 
age. Ultrasound imaging revealed a localized (1.9 
f 0.5 cm*), transient (744 f 733 ms), cavitation 
field at the focal point at the time of application of 
focused shock waves. Thus, focused high-power 
acoustic energy can effect noninvasive thrombus 
ablation without apparent damage to the arterial 
wall. The mechanism underlying shock-wave 
thrombus ablation may be associated with the car 
itation effect. 
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A cute thrombosis of the coronary and peripheral arteries is the major cause of morbidity and mortality. Despite major advances in thrombo- 
lytic therapy for acute myocardial infarction, it still has 
considerable shortcomings. Approximately 30% of pa- 
tients with acute myocardial infarction are eligible for 
thrombolytic therapy, and early reperfusion rates are 
approximately 7O%.l Because of these limitations, more 
efficient and applicable therapies are being vigorously 
investigated. Rosenschein et aP3 have reported the de- 
velopment of high-power, low-frequency, ultrasound 
catheter for arterial recanalization. This method was in- 
vestigated both in experimental and clinical settings. 
These studies suggest that high-power, acoustic energy 
selectively ablates thrombi with a wide margin of safety. 
We hypothesized that high-power acoustic energy from 
an external acoustic generator can be focused and con- 
verged into the body to induce selective ablation of a 
target thrombus. The goal of this study was to test the 
feasibility of noninvasive acoustic thrombus ablation in 
a thrombotic artery model in vitro. 
METHODS 
lhrombotic artery model preparation: Human fem- 
oral and iliac arteries were obtained during postmortem 
examinations. The arterial segments were fmed in 10% 
neutral formalin for 24 hours, and then transferred to a 
saline solution and kept at 4°C for <7 days. Every 48 
hours, the saline solution was changed. Fresh thrombus 
was prepared by filling a 3 mm diameter plastic tube 
with fresh, human blood mixed with thrombin (1 ml 
blood/20 NIH unit bovine thrombin, T4648, Sigma, St. 
Louis, Missouri). After 30 minutes, the thrombus was 
removed from the plastic tube and dissected to a length 
approximately one third that of each arterial segment. 
The thrombus was weighed (Model AB-4, Christian 
Becker, Germany) and inserted in the artery. The ar- 
tery was filled with saline solution to preclude an artifi- 
cial acoustic interface between air and fluid (i.e., air 
bubbles), and ligated at both ends. 
Shock-wave ablation pro&ok A shock-wave litho- 
tripter (HM3, Dormer Medical Systems, Marietta, 
Georgia) was used as a source for focused, high-power, 
acoustic energy. Underwater, high-current, electrical 
spark-gap discharges (pulse duration approximately 1 
ms) generated underwater explosive vaporization of wa- 
ter between the spark-gap electrodes. This generated 
shock waves in the surrounding fluid, which propagated 
spherically from the site of origin. Positioning the spark- 
gap electrode in a symmetric, hemi-ellipsoid, metal re- 
flector focused the shock waves. The reflector reflects 
and converges the shock waves at a focal point where 
90% of the energy is concentrated on a spherical area 
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approximately 2 cm in diameter. The distance between 
the spark-gap and focal point is 22.5 cm. 
The thrombotic arterial segments were randomized 
into test (n = 8) and control groups (n = 7). Transillu- 
mination confirmed the position of the thrombus in the 
artery. Radiopaque markers on both sides of the throm- 
bus identified and defined the thrombotic section during 
application of shock waves. Each segment was suspend- 
ed from a metal frame and immersed in a water bath. 
The water was kept at constant temperature (35 f 
1°C). The metal frame with the suspended thrombotic 
artery could be moved along 3 spatial axes by means of 
a motor-driven, positioning device. An x-ray location 
system, using 2 independent, image conversion systems 
arranged along nonparallel axes, verified the 3-dimen- 
sional positioning of the thrombotic segment at the in- 
tersection of the 2 nonparallel axes (i.e., focal point) 
(Figure 1). The test arteries were exposed to 1,000 
shocks at 24 kv. This dosage was chosen with regard to 
the 500 to 1,500 discharges to which patients are typi- 
cally exposed, and based on experience derived from an- 
imal studies of shock-wave-induced tissue damage.4 
The control arteries underwent identical treatment, but 
without exposure to shock waves. 
After the application of shock waves, the arterial lig- 
atures were removed, and the arterial content was 
flushed with 10 ml of saline solution. The residual solid 
thrombus was separated from the fluid portion and re- 
weighed. The extent of thrombus ablation was evaluat- 
ed from the change in solid thrombus weight. 
Histopathologic analysis: The arterial segments and 
thrombi were fixed in 10% neutral formalin. From each 
segment, 4 rings were excised and processed routine- 
ly. Sections were mounted on glass slides and stained 
with hematoxylin-eosin and Movat-pentachrome stains. 
An experienced cardiovascular pathologist (GDA) un- 
aware of the experimental details and results performed 
the pathologic evaluations. The overall integrity of the 
vessel, continuity of the elastic structures, and cellu- 
lar damage were assessed in the arterial segments. 
The composition and architecture were studied in the 
thrombi. 
Cavitation analysis: An ultrasound imaging syste:n 
was used to study the production of cavitation by he 
shock waves to elucidate the mechanism of shock-wave 
thrombus ablation.3 A 5 MHz multi-element linear- 
phase array ultrasound imaging transducer, with an axi- 
al resolution of 0.3 mm and a lateral resolution of 1.2 
mm, at a depth of 4 cm (Ultramark 9, Advanced Tech- 
nology Laboratories, Inc., Bothell, Washington), im- 
aged the arterial segment in the water bath before, dur- 
ing and after each experiment. The ultrasound image on 
display was continuously recorded on a videotape with 
240 videolines of resolution (AG 6300 Panasonics). 
Cavitations were defined as highly echogenic, transient 
microbubbles on the ultrasound image display.3 Qua- 
druplicates of the maximal area of each cavitation field 
were measured and averaged (Freeland Systems, Prism 
Imaging, Chicago, Illinois). The times from the spark- 
gap discharge to the earliest production of cavitation, to 
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attainment of maximal area of the cavitation field and 
to final clearance of the cavitation were measured in 10 
cycles of application of shock waves and averaged. Time 
was measured by counting the number of videoframes 
FIGURE 2. A, we histobgk section of arterial seg- 




of me&a (a#rows), slmlb to that bl canbd, is aeifact of ban- 
&ng.B,fepmmMk~sectienofcontrolartwtal 
segment not exposed to h&power, acoustk snergy. Strut- 
tudfdWVSOfthiSWSSdiWV?Vlrlnraly-tOtbO&WOf 
vesselafterexposwe. (Movatpenhhmestain; XlzO,re- 
duad by 30%.) 
from the spark-gap discharge (recorded as electrical in- 
terference on the ultrasound image) to the event and 
multiplying by 33 ms (at frame rate of 30 frames/s; 
each frame represents 33 ms). Echocardiographic stud- 
ies were performed with and without the presence of an 
arterial segment at focal point to determine the contri- 
bution of acoustic impedance mismatch between the ar- 
terial segment and water to the production of cavitation. 
Statistical analysis: Data were summarized as mean 
f SD. Differences between groups were analyzed using 
the unpaired, 2-tailed Student’s t test. A p value <0.05 
was considered significant. 
RESULTS 
Thrombus ablation: The thrombus generated in vi- 
tro had a diameter of 3 mm, length of 3.2 f 0.4 cm, 
and weight of 0.24 f 0.08 g. In the test group, applica- 
tion of shock waves dramatically reduced the weight of 
solid thrombus (0.25 f 0.16 vs 0.07 f 0.003 g; p = 
0.0001). 
Histopathdogic analysis: After application of shock 
waves, there were no perforations or other gross signs of 
damage to the arterial segments. Histologic examina- 
tion revealed occasional cleavage planes between the in- 
tima and media along the internal elastic membrane, 
and between the media and adventitia along the exter- 
nal elastic membrane. These cleavage planes were simi- 
lar in magnitude in both groups. Accordingly, these 
breaks were attributed to handling and processing, rath- 
er than to acoustic trauma.5 The variability of the elas- 
tic fibers in the internal elastic lamina, which is associ- 
ated with the existence of arteriosclerotic changes, was 
in similar proportions in both groups. Otherwise, no 
change in the architecture of the arterial wall was ob- 
served (Figure 2). No cellular damage was noted in the 
intima, media or adventitia. The residual thrombi in 
both groups were identical in composition and structure. 
Cavitation analysis: Immediately after the applica- 
tion of shock waves (133 ms), a localized, transient, 
dense field of cavitation was formed at the focal point, 
the site of maximal energy density, encompassing the 
thrombotic arterial segment. The field of cavitation at- 
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tained its maximal dimension (1.9 f 0.5 cm2) within 
129 f 62 ms; thereafter, it gradually declined in size 
and density. After 744 f 233 ms, only a few.stable cavi- 
tations were apparent at the focal point (Figure 3). The 
production of cavitation after the application of shock 
waves was characteristic and independent of the pres- 
ence of an arterial segment at the focal point. 
DISCUSSION 
The biological use of focused, high-intensity, acous- 
tic energy was first studied by Lynn et al6 in 1942. They 
demonstrated that focused, acoustic energy can produce 
deep, localized damage at the focal point in various bio- 
logical tissues in vitro and in vivo, with minimal effect 
on the surface and no effect on the intervening tissue. 
Approximately 30 years later, the use of focused, acous- 
tic energy reemerged in the biomedical field. Experi- 
mental investigation in the use of focused shock waves 
has led to nonsurgical treatment of upper urinary tract 
calculi7 Extensive experience with shock-wave lithotrip- 
sy has demonstrated the method to be safe and highly 
effective.738 
This study is the first to show the feasibility of using 
focused, acoustic energy for noninvasive, targeted and 
selective thrombus ablation. When thrombotic human 
arterial segments were placed at the focal point of fo- 
cused shock waves, a significant ablation of thrombus 
with no apparent damage to the arterial wall was ob- 
served. However, the absence of cellular damage in vi- 
tro is limited evidence for the safety of this method. 
Further in vivo experiments will be needed to confirm 
the safety of shock-wave thrombus ablation. The small 
reduction in thrombus weight observed in the control 
group is mainly attributable to clot retraction between 
the time of thrombus induction and the ablation experi- 
ment (12 f 3 hours). 
The data, documenting the effective and selective 
noninvasive thrombus ablation by high-power, acoustic 
energy, are consistent with those in studies of ultrasonic 
thrombus ablation by acoustic energy transmitted by a 
catheter.2J Those studies also show that the level of 
acoustic energy necessary to ablate thrombus has a min- 
imal effect on the arterial wall. 
The mechanism of shock-wave lithotripsy is believed 
to be associated with the acoustic impedance mismatch 
between the target calculus and surrounding soft tissue. 
When the shock waves reach the target, the presence of 
the acoustic impedance mismatch produces pressure 
changes of magnitudes sufficient*for shuttering the tar- 
get calculus? In this study, shock waves effected throm- 
bus ablation despite the similarities in impedance prop- 
erties between the fresh thrombus and the surrounding 
water, suggesting that a different mechanism may be 
operating here. During shock-wave thrombus ablation, 
a localized, transient field of cavitation is produced at 
the focal point encompassing the target thrombotic ar- 
tery. Cavitations are believed to be responsible for the 
thrombus ablation in ultrasonic angioplasty.3 These 
generate localized disruptive mechanical forces capable 
of degrading several polymers,loJ1 including fibrin poly- 
mer that forms the structural basis of solid thrombus. In 
ultrasonic thrombus ablation, the cavitation effect dis- 
rupts the fibrin polymer with the generation of an abun- 
dance of fibrin fragments.2 Thus, the data suggest that 
the localized production of cavitation at the pont of 
maximal, acoustic energy density may be important in 
the mechanism for thrombus ablation. 
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